Thursday, November 23, 2017

Oncogene - Table of Contents alert Volume 36 Issue 47

If you are unable to see the message below, click here to view.
Oncogene
TABLE OF CONTENTS

Volume 36, Issue 47 (November 2017)

In this issue
Original Articles
Corrigendum

Also new
AOP
 
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Original Articles

Top

Deficiency in VHR/DUSP3, a suppressor of focal adhesion kinase, reveals its role in regulating cell adhesion and migration

Y-R Chen, H-C Chou, C-H Yang, H-Y Chen, Y-W Liu, T-Y Lin, C-L Yeh, W-T Chao, H-H Tsou, H-C Chuang and T-H Tan

Oncogene 2017 36: 6509-6517; advance online publication, July 31, 2017; 10.1038/onc.2017.255

Abstract | Full Text

TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis OPEN

Y Zhou, T Huang, J Zhang, C C Wong, B Zhang, Y Dong, F Wu, J H M Tong, W K K Wu, A S L Cheng, J Yu, W Kang and K F To

Oncogene 2017 36: 6518-6530; advance online publication, July 31, 2017; 10.1038/onc.2017.257

Abstract | Full Text

Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis

P Chiodelli, S Rezzola, C Urbinati, F Federici Signori, E Monti, R Ronca, M Presta and M Rusnati

Oncogene 2017 36: 6531-6541; advance online publication, August 7, 2017; 10.1038/onc.2017.243

Abstract | Full Text

EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasis OPEN

C-H Shih, Y-J Chang, W-C Huang, T-H Jang, H-J Kung, W-C Wang, M-H Yang, M-C Lin, S-F Huang, S-W Chou, E Chang, H Chiu, T-Y Shieh, Y-J Chen, L-H Wang and L Chen

Oncogene 2017 36: 6542-6554; advance online publication, July 31, 2017; 10.1038/onc.2017.262

Abstract | Full Text

Role of HSPA1L as a cellular prion protein stabilizer in tumor progression via HIF-1α/GP78 axis

J H Lee, Y-S Han, Y M Yoon, C W Yun, S P Yun, S M Kim, H Y Kwon, D Jeong, M J Baek, H J Lee, S-J Lee, H J Han and S H Lee

Oncogene 2017 36: 6555-6567; advance online publication, July 31, 2017; 10.1038/onc.2017.263

Abstract | Full Text

Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression

P A Guerrero, J H Tchaicha, Z Chen, J E Morales, N McCarty, Q Wang, E P Sulman, G Fuller, F F Lang, G Rao and J H McCarty

Oncogene 2017 36: 6568-6580; advance online publication, August 7, 2017; 10.1038/onc.2017.248

Abstract | Full Text

Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancers

A N Hata, S Rowley, H L Archibald, M Gomez-Caraballo, F M Siddiqui, F Ji, J Jung, M Light, J S Lee, L Debussche, S Sidhu, R I Sadreyev, J Watters and J A Engelman

Oncogene 2017 36: 6581-6591; advance online publication, August 7, 2017; 10.1038/onc.2017.258

Abstract | Full Text

Loss of claudin-3 expression induces IL6/gp130/Stat3 signaling to promote colon cancer malignancy by hyperactivating Wnt/β-catenin signaling

R Ahmad, B Kumar, Z Chen, X Chen, D Müller, S M Lele, M K Washington, S K Batra, P Dhawan and A B Singh

Oncogene 2017 36: 6592-6604; advance online publication, August 7, 2017; 10.1038/onc.2017.259

Abstract | Full Text

The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma OPEN

O Govaere, M Petz, J Wouters, Y-P Vandewynckel, E J Scott, B Topal, F Nevens, C Verslype, Q M Anstee, H Van Vlierberghe, W Mikulits and T Roskams

Oncogene 2017 36: 6605-6616; advance online publication, August 7, 2017; 10.1038/onc.2017.260

Abstract | Full Text

Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model

L D’Abundo, E Callegari, A Bresin, A Chillemi, B K Elamin, P Guerriero, X Huang, E Saccenti, E M A A Hussein, F Casciano, P Secchiero, G Zauli, G A Calin, G Russo, L J Lee, C M Croce, G Marcucci, S Sabbioni, F Malavasi and M Negrini

Oncogene 2017 36: 6617-6626; advance online publication, August 7, 2017; 10.1038/onc.2017.269

Abstract | Full Text

Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3 OPEN

T Zhang, J Li, F Yin, B Lin, Z Wang, J Xu, H Wang, D Zuo, G Wang, Y Hua and Z Cai

Oncogene 2017 36: 6627-6639; advance online publication, August 7, 2017; 10.1038/onc.2017.270

Abstract | Full Text

Short stretches of rare codons regulate translation of the transcription factor ZEB2 in cancer cells OPEN

W R Wan Makhtar, G Browne, A Karountzos, C Stevens, Y Alghamdi, A R Bottrill, S Mistry, E Smith, M Bushel, J H Pringle, A E Sayan and E Tulchinsky

Oncogene 2017 36: 6640-6648; advance online publication, August 7, 2017; 10.1038/onc.2017.273

Abstract | Full Text

P38 delta MAPK promotes breast cancer progression and lung metastasis by enhancing cell proliferation and cell detachment

M Wada, D Canals, M Adada, N Coant, M F Salama, K L Helke, J S Arthur, K R Shroyer, K Kitatani, L M Obeid and Y A Hannun

Oncogene 2017 36: 6649-6657; advance online publication, August 7, 2017; 10.1038/onc.2017.274

Abstract | Full Text

Corrigendum

Top

Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1

G M Sizemore, S Balakrishnan, A M Hammer, K A Thies, A J Trimboli, J A Wallace, S T Sizemore, R D Kladney, S A Woelke, L Yu, S A Fernandez, A Chakravarti, G Leone and M C Ostrowski

Oncogene 2017 36: 6658; advance online publication, October 16, 2017; 10.1038/onc.2017.347

Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature